We are UCB

We are UCB

Welcome to our
2019 Integrated Annual Report!

Our 2019 Integrated Annual Report is a step on our journey to provide you with the best possible information on how UCB creates value for patients with severe diseases and for our societal stakeholders now and into the future. Today, more than ever, our 7 606 colleagues aspire to become the Patient Preferred Biopharma Leader!

Jorge, Corinne, Yuko, Benedicte, UCB (photo)
Jorge, Corinne, Yuko, Benedicte, UCB

About this annual report

This Integrated Annual Report 2019 includes the manage­ment report in accordance with article 12 of the Royal Decree of 14 November 2007 relating to the obligations of issuers of financial instruments admitted to trading on a regulated market. All information required to be included in such management report pursuant to articles 3:6 and 3:32 of the Belgian Code of Companies and Associations (i.e. Corporate Governance Statement – Remuneration Report included –, Business Performance Review and UCB’s Statement on non-financial information) is reported throughout all different sections of this Integrated Annual Report. This 2019 Integrated Annual Report together with the materiality assessment have been prepared in accordance with the Global Reporting Standards: Core option. Non-financial information is also audited by a third party.

A global biopharmaceutical company. Inspired by patients. Driven by science.

At UCB, we are committed to bringing innovative therapies and solutions to address significant unmet needs for people with severe chronic diseases. UCB has its headquarters in Belgium and our 7 606 employees across 36 markets put patients at the heart of everything they do, driving our decisions and actions to bring innovative and differentiated solutions to people in our two primary therapeutic areas of neurology and immunology.

Click to explore

  • International markets – others

    International markets – others

    UCB has affiliates in Australia, Brazil, Canada, Hong Kong, India, Mexico, Russia, South Korea, Taiwan, Turkey, Ukraine

    704 employees

    9% of global

    54% women

    46% men

    € 418 million

    9% of global net sales 1

    1 Global net sales excluding hedging

  • U.S.

    Atlanta, GA

    • Affiliate

    Raleigh, NC

    • Development

    Boston, MA

    • Research

    Seattle, WA

    • Research

    1 403 employees

    18% of global

    57% women

    43% men

    € 2 546 million

    54% of global net sales 1

    1 Global net sales excluding hedging

    • 100% electricity from renewable sources (Atlanta)
  • Switzerland

    Bulle

    • Affiliate
    • Production

    509 employees

    7% of global

    37% women

    63% men

    • ISO14001 certified
    • OHSAS 18001 certified
    • Solar panels installed
    • 100% electricity from renewable sources

    € 40 million

    1% of global net sales 1

    1 Global net sales excluding hedging

  • Europe – others

    Europe – others

    UCB has affiliates in Austria, Bulgaria, Czech Republic, Denmark, Finland, France, Greece, Hungary, Ireland, Italy, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Spain, Sweden

    600 employees

    8% of global

    62.5% women

    37.5% men

    € 820 million

    17% of global net sales 1

    1 Global net sales excluding hedging

  • U.K.

    Slough

    • Affiliate
    • Research
    • Development

    714 employees

    9% of global

    53% women

    47% men

    • ISO14001 certified
    • OHSAS 18001 certified
    • 93% electricity from renewable sources

    € 97 million

    2% of global net sales 1

    1 Global net sales excluding hedging

  • Belgium

    Brussels

    • HQ
    • Affiliate

    Braine-l’Alleud

    • Production
    • Research
    • Development

    2 318 employees

    30% of global

    46% women

    54% men

    € 42 million

    1% of global net sales 1

    1 Global net sales excluding hedging

    • ISO14001 certified (Braine)
    • Solar panels installed (Brussels and Braine)
    • 100% electricity from renewable sources
  • Germany

    Monheim

    • Affiliate
    • Development

    442 employees

    6% of global

    60% women

    40% men

    • 100% electricity from renewable sources

    € 333 million

    7% of global net sales 1

    1 Global net sales excluding hedging

  • Japan

    Tokyo

    • Affiliate
    • Development
    • Production

    Saitama

    • Production

    469 employees

    6% of global

    22% women

    78% men

    € 368 million

    8% of global net sales 1

    1 Global net sales excluding hedging

    • ISO14001 certified
    • ISO45001 certified
    • 100% electricity from renewable sources (production)
  • China

    Shanghai

    • Affiliate
    • Development

    Zhuhai

    • Production

    447 employees

    6% of global

    59% women

    41% men

    € 137 million

    3% of global net sales 1

    1 Global net sales excluding hedging

    • ISO14001 certified
    • OHSAS 18001 certified
  • Revenue

    in € million

    4 913

    2018: 4 632

  • rEBITDA/revenue
    ratio

    29.1%

    2018: 30.2%

  • Number of assets in pipeline

    7

    2018: 10

  • R&D/revenue
    ratio

    26%

    2018: 25%

  • 7 606

    UCB employees world-wide

  • 50

    %

    Women

    50

    %

    Men

  • 33

    %

    Women Executive level

    38

    %

    Women Board Member

  • Reduction in CO2 emissions

    −35%

    2018: −30%

  • UCB focuses on the following UN Sustainable Development Goals:

See Our performance